John Stephen Healy - Mar 1, 2022 Form 3 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
General Counsel and Secretary
Signature
/s/ John Stephen Healy
Stock symbol
TYRA
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
3
Date filed
3/3/2022, 05:39 PM
Next filing
Jun 3, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TYRA Stock Option (Right to Buy) Mar 1, 2022 Common Stock 51.9K $2.25 Direct F1
holding TYRA Stock Option (Right to Buy) Mar 1, 2022 Common Stock 135K $10.75 Direct F2
holding TYRA Stock Option (Right to Buy) Mar 1, 2022 Common Stock 83.6K $24.15 Direct F3
holding TYRA Stock Option (Right to Buy) Mar 1, 2022 Common Stock 7.96K $24.15 Direct F4
holding TYRA Stock Option (Right to Buy) Mar 1, 2022 Common Stock 7.96K $24.15 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly following February 26, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
F2 25% of the shares subject to the option shall vest on March 5, 2022, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
F3 1/48th of the shares subject to the option vest monthly following November 2, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
F4 The option vests based on achievement of a performance objective.